vs
Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and SuperCom Ltd (SPCB). Click either name above to swap in a different company.
SuperCom Ltd is the larger business by last-quarter revenue ($14.2M vs $7.8M, roughly 1.8× CRYO CELL INTERNATIONAL INC). SuperCom Ltd runs the higher net margin — 37.5% vs -48.7%, a 86.2% gap on every dollar of revenue. On growth, SuperCom Ltd posted the faster year-over-year revenue change (-1.5% vs -2.3%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $-3.6M).
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
Super.com is a technology company headquartered in San Francisco and co-founded by Hussein Fazal and Henry Shi. The company provides financial services, including reward programs and travel bookings.
CCEL vs SPCB — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.8M | $14.2M |
| Net Profit | $-3.8M | $5.3M |
| Gross Margin | 77.9% | 61.2% |
| Operating Margin | -50.6% | 16.3% |
| Net Margin | -48.7% | 37.5% |
| Revenue YoY | -2.3% | -1.5% |
| Net Profit YoY | -105.1% | 79.5% |
| EPS (diluted) | $-0.46 | $1.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.8M | — | ||
| Q3 25 | $7.8M | — | ||
| Q2 25 | $7.9M | $14.2M | ||
| Q1 25 | $8.0M | — | ||
| Q4 24 | $8.0M | — | ||
| Q3 24 | $8.1M | — | ||
| Q2 24 | $8.0M | $14.4M | ||
| Q1 24 | $7.9M | — |
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $749.4K | — | ||
| Q2 25 | $355.8K | $5.3M | ||
| Q1 25 | $282.9K | — | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $1.1M | — | ||
| Q2 24 | $655.8K | $3.0M | ||
| Q1 24 | $556.2K | — |
| Q4 25 | 77.9% | — | ||
| Q3 25 | 77.0% | — | ||
| Q2 25 | 76.6% | 61.2% | ||
| Q1 25 | 75.1% | — | ||
| Q4 24 | 78.4% | — | ||
| Q3 24 | 73.6% | — | ||
| Q2 24 | 74.8% | 52.3% | ||
| Q1 24 | 73.7% | — |
| Q4 25 | -50.6% | — | ||
| Q3 25 | 24.3% | — | ||
| Q2 25 | 18.8% | 16.3% | ||
| Q1 25 | 13.3% | — | ||
| Q4 24 | -1.5% | — | ||
| Q3 24 | 17.2% | — | ||
| Q2 24 | 17.3% | 7.7% | ||
| Q1 24 | 10.5% | — |
| Q4 25 | -48.7% | — | ||
| Q3 25 | 9.6% | — | ||
| Q2 25 | 4.5% | 37.5% | ||
| Q1 25 | 3.5% | — | ||
| Q4 24 | -23.2% | — | ||
| Q3 24 | 13.0% | — | ||
| Q2 24 | 8.2% | 20.6% | ||
| Q1 24 | 7.1% | — |
| Q4 25 | $-0.46 | — | ||
| Q3 25 | $0.09 | — | ||
| Q2 25 | $0.04 | $1.32 | ||
| Q1 25 | $0.03 | — | ||
| Q4 24 | $-0.23 | — | ||
| Q3 24 | $0.13 | — | ||
| Q2 24 | $0.08 | $1.19 | ||
| Q1 24 | $0.07 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.3M | $15.0M |
| Total DebtLower is stronger | $8.4M | $23.6M |
| Stockholders' EquityBook value | $-18.6M | $37.3M |
| Total Assets | $61.7M | $65.5M |
| Debt / EquityLower = less leverage | — | 0.63× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.3M | — | ||
| Q3 25 | $3.2M | — | ||
| Q2 25 | $4.4M | $15.0M | ||
| Q1 25 | $3.5M | — | ||
| Q4 24 | $3.5M | — | ||
| Q3 24 | $2.1M | — | ||
| Q2 24 | $1.5M | $5.7M | ||
| Q1 24 | $979.6K | — |
| Q4 25 | $8.4M | — | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $8.4M | $23.6M | ||
| Q1 25 | $8.5M | — | ||
| Q4 24 | $8.5M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | $29.2M | ||
| Q1 24 | $8.6M | — |
| Q4 25 | $-18.6M | — | ||
| Q3 25 | $-14.8M | — | ||
| Q2 25 | $-15.6M | $37.3M | ||
| Q1 25 | $-14.7M | — | ||
| Q4 24 | $-13.2M | — | ||
| Q3 24 | $-9.6M | — | ||
| Q2 24 | $-10.7M | $13.8M | ||
| Q1 24 | $-10.3M | — |
| Q4 25 | $61.7M | — | ||
| Q3 25 | $63.2M | — | ||
| Q2 25 | $64.4M | $65.5M | ||
| Q1 25 | $64.4M | — | ||
| Q4 24 | $64.7M | — | ||
| Q3 24 | $62.9M | — | ||
| Q2 24 | $62.6M | $49.6M | ||
| Q1 24 | $61.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.63× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 2.11× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3M | $-2.2M |
| Free Cash FlowOCF − Capex | $1.2M | $-3.6M |
| FCF MarginFCF / Revenue | 15.5% | -25.3% |
| Capex IntensityCapex / Revenue | 0.9% | 10.0% |
| Cash ConversionOCF / Net Profit | — | -0.41× |
| TTM Free Cash FlowTrailing 4 quarters | $5.2M | $-14.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3M | — | ||
| Q3 25 | $2.5M | — | ||
| Q2 25 | $707.0K | $-2.2M | ||
| Q1 25 | $954.1K | — | ||
| Q4 24 | $2.2M | — | ||
| Q3 24 | $2.4M | — | ||
| Q2 24 | $1.8M | $-950.0K | ||
| Q1 24 | $-356.9K | — |
| Q4 25 | $1.2M | — | ||
| Q3 25 | $2.5M | — | ||
| Q2 25 | $644.6K | $-3.6M | ||
| Q1 25 | $892.0K | — | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $2.3M | — | ||
| Q2 24 | $21.5K | $-1.6M | ||
| Q1 24 | $-814.6K | — |
| Q4 25 | 15.5% | — | ||
| Q3 25 | 31.9% | — | ||
| Q2 25 | 8.1% | -25.3% | ||
| Q1 25 | 11.2% | — | ||
| Q4 24 | 26.8% | — | ||
| Q3 24 | 27.9% | — | ||
| Q2 24 | 0.3% | -10.8% | ||
| Q1 24 | -10.4% | — |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.8% | 10.0% | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 21.8% | 4.2% | ||
| Q1 24 | 5.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 3.38× | — | ||
| Q2 25 | 1.99× | -0.41× | ||
| Q1 25 | 3.37× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.32× | — | ||
| Q2 24 | 2.70× | -0.32× | ||
| Q1 24 | -0.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
